NCT00680056View on ClinicalTrials.gov

Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Pulmonary Disease, Chronic ObstructiveChronic BronchitisPulmonary Emphysema
Interventions
DRUG

Formoterol plus Placebo (Tiotropium)

Formoterol 12mcg-capsules (2x/d) + Placebo (Tiotropium) (1x/d). Double-blind medication will be dispensed in HandiHalers and Aerolisers during 2 weeks.

DRUG

Formoterol plus Tiotropium

Formoterol 12mcg-capsule (2x/dia) + Tiotropium 18mcg-capsule (1x/d). Double-blind medication will be dispensed in HandiHalers and Aerolisers during 2 weeks.

Trial Locations (1)

04020-050

Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00680056 - Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients | Biotech Hunter | Biotech Hunter